Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

Authors:

Abstract
No abstract available
Funding Information
  • AstraZeneca
  • Optimum Patient Care
  • AstraZeneca UK Limited

This publication has 44 references indexed in Scilit: